MBX
Price
$17.90
Change
+$0.40 (+2.29%)
Updated
Oct 1 closing price
Capitalization
800.41M
35 days until earnings call
QLGN
Price
$6.01
Change
+$0.29 (+5.07%)
Updated
Oct 1 closing price
Capitalization
9.7M
Interact to see
Advertisement

MBX vs QLGN

Header iconMBX vs QLGN Comparison
Open Charts MBX vs QLGNBanner chart's image
MBX Biosciences
Price$17.90
Change+$0.40 (+2.29%)
Volume$947.1K
Capitalization800.41M
Qualigen Therapeutics
Price$6.01
Change+$0.29 (+5.07%)
Volume$586.72K
Capitalization9.7M
MBX vs QLGN Comparison Chart in %
Loading...
MBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBX vs. QLGN commentary
Oct 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBX is a StrongBuy and QLGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 02, 2025
Stock price -- (MBX: $17.90 vs. QLGN: $6.01)
Brand notoriety: MBX and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBX: 72% vs. QLGN: 28%
Market capitalization -- MBX: $800.41M vs. QLGN: $9.7M
MBX [@Biotechnology] is valued at $800.41M. QLGN’s [@Biotechnology] market capitalization is $9.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.64B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBX’s FA Score shows that 1 FA rating(s) are green whileQLGN’s FA Score has 2 green FA rating(s).

  • MBX’s FA Score: 1 green, 4 red.
  • QLGN’s FA Score: 2 green, 3 red.
According to our system of comparison, QLGN is a better buy in the long-term than MBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBX’s TA Score shows that 6 TA indicator(s) are bullish while QLGN’s TA Score has 5 bullish TA indicator(s).

  • MBX’s TA Score: 6 bullish, 3 bearish.
  • QLGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MBX is a better buy in the short-term than QLGN.

Price Growth

MBX (@Biotechnology) experienced а -10.95% price change this week, while QLGN (@Biotechnology) price change was +45.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +12.74%, and the average quarterly price growth was +77.34%.

Reported Earning Dates

MBX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBX($800M) has a higher market cap than QLGN($9.7M). QLGN YTD gains are higher at: 42.755 vs. MBX (-5.046). QLGN has higher annual earnings (EBITDA): -6.28M vs. MBX (-86.29M). MBX has more cash in the bank: 225M vs. QLGN (332K). MBX has less debt than QLGN: MBX (650K) vs QLGN (3.62M). MBX (0) and QLGN (0) have equivalent revenues.
MBXQLGNMBX / QLGN
Capitalization800M9.7M8,248%
EBITDA-86.29M-6.28M1,373%
Gain YTD-5.04642.755-12%
P/E RatioN/A0.95-
Revenue00-
Total Cash225M332K67,771%
Total Debt650K3.62M18%
FUNDAMENTALS RATINGS
QLGN: Fundamental Ratings
QLGN
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MBXQLGN
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 22 days ago
89%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
MBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADGAX26.41N/A
N/A
AB Core Opportunities A
SLVCX18.26N/A
N/A
Saratoga Large Capitalization Value C
TIERX9.59N/A
N/A
Nuveen International Eq A
JPVZX18.25N/A
N/A
JPMorgan Developed International ValueR2
JRSAX13.20N/A
N/A
JH Adaptive Risk Mgd U.S. Eq A

MBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBX has been loosely correlated with KOD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MBX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBX
1D Price
Change %
MBX100%
-2.45%
KOD - MBX
45%
Loosely correlated
+3.54%
QLGN - MBX
37%
Loosely correlated
+6.32%
VTGN - MBX
35%
Loosely correlated
+0.28%
VTYX - MBX
33%
Loosely correlated
+2.81%
RARE - MBX
33%
Poorly correlated
-0.92%
More

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with MBX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then MBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
+5.07%
MBX - QLGN
37%
Loosely correlated
+2.29%
NTLA - QLGN
34%
Loosely correlated
+8.63%
KOD - QLGN
33%
Poorly correlated
-3.73%
PHIO - QLGN
32%
Poorly correlated
-2.42%
ZLDAF - QLGN
29%
Poorly correlated
N/A
More